| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |